The clinical pharmacology of new benzylisochinoline diester compounds. With particular attention to cisatracurium and mivacurium;DIE KLINISCHE PHARMAKOLOGIE NEUER BENZYLISOCHINOLIN-DIESTER-VERBINDUNGEN THE CLINICAL PHARMACOLOGY OF NEW BENZYLISOCHINOLINE DIESTER COMPOUNDS. WITH PARTICULAR ATTENTION TO CISATRACURIUM AND MIVACURIUM

Anaesthesist

Volumn 46, Issue 10, 1997, Pages 840-849

  Savarese, J J ^a   Lien, Cynthia A ^a   Belmont, M R ^a   Wastila, W B ^b   Buzello, W ^c  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b GLAXOSMITHKLINE   (United States)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Benzylisochinoline; Cisatracurium; Mivacurium; Muscle relaxants

Indexed keywords

ATRACURIUM; MIVACURIUM; CISATRACURIUM; DRUG DERIVATIVE; ISOQUINOLINE DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT;

CLINICAL PHARMACOLOGY; DRUG ACTIVITY; DRUG ELIMINATION; HUMAN; KINETICS; MUSCLE RELAXATION; NEUROMUSCULAR BLOCKING; REVIEW; STEREOISOMERISM; ANESTHESIA;

ANESTHESIA; ATRACURIUM; HUMANS; ISOQUINOLINES; NEUROMUSCULAR NONDEPOLARIZING AGENTS;

EID: 0031254560     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001010050477     Document Type: Review

References (27)

1. Ali HH, Lien CA, Witkowski T et al. (1996) Efficacy and safety of divided dose administration of mivacurium for a 90-second tracheal intubation. J Clin Anesth 8:276-281
2. Belmont MR, Lien CA, Quessy S et al. (1995) The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 82:1139-1145
3. Bowman WC, Rodger IW, Houston J, Marshall RJ, McIndewar I (1988) Structure-action relationship among some desacetoxy analogues of pancuronium and vecuronium in the anesthetized cat. Anesthesiology 69:57-64
4. Boyd AH, Eastwood NB, Parker CJR, Hunter JM (1995) Pharmacokinetics of the 1 R cis - 1' R cis isomer of atracurium (51W89) in health and chronic renal failure. Br J Anaesth 74:400-404
5. Cook DR, Freeman JA, Lai AA et al. (1991) Pharmacokinetics and pharmacodynamics of doxacurium in normal patients and in those with hepatic or renal failure. Anesth Analg 72:145-150
6. Cook DR, Freeman JA, Lai AA et al. (1992) Pharmacokinetics of mivacurium in normal patients and in those with hepatic or renal failure. Br J Anaesth 69:580-585
7. Fahey MR, Rupp SM, Fisher DMWR et al. (1984) The pharmacokineticsand pharmacodynamics of atracurium in patients with and without renal failure. Anesthesiology 61:699-705
8. Goudsouzian NG, D'Hollander AA, Viby-Mogensen J (1993) Prolonged neuromuscular block from mivacurium in two patients with cholinesterase deficiency. Anesth Analg 77:183-187
9. Hart PS, McCarthy GJ, Brown R, Lau M, Fisher DM (1995) The effect of plasma cholinesterase activity on mivacurium infusion rates. Anesth Analg 80:760-763
10. Lien CA, Schmith VD, Embree PB, Belmont MR, Wargin WA, Savarese JJ (1994) The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/ barbiturate anesthesia. Anesthesiology 80:1296-1302
11. Lien CA, Belmont MR, Abalos A et al. (1995) The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide-opioid-barbiturate anesthesia. Anesthesiology 82:1131-1138
12. Lien CA, Belmont MR, Wray DL, Okamoto M, Abalos A, Savarese JJ (1995) Pharmacokinetics and dynamics of mivacurium during spontenous recovery and anticholinesterase-facilitated recovery. Anesthesiology 83:A896
13. Lien CA, Schmith VD, Belmont MR, Abalos A, Kisor DF, Savarese J (1996) Pharmacokinetics of cisatracurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 84:300-308
14. Naguib M, Daoud W, El-Gammal M et al. (1995) Enzymatic antagonism of mivacurium-induced neuromuscular blockade by human plasma cholinesterase. Anesthesiology 83:694-701
15. Ornstein E, Lien CA, Matteo RS et al. (1996) Pharmacodynamics and pharmacokinetics of cisatracurium in geriatric surgical patients. Anesthesiology 84:520-525
16. Parker CJR, Jones JE, Hunter JM (1988) Disposition of infusions of atracurium and its metabolite laudanosine, in patients in renal and respiratory failure in an ITU. Br J Anesth 61:531-540
17. Plaud B, Debaene B, Legueau F, Meistelman C, Donati F (1996) Mivacurium neuromuscular block at the adductor muscles of the larynx and adductor pollicis in humans. Anesthesiology 85:77-81
18. Savarese JJ, Ali HH, Basta SJ et al. (1988) The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U) A short-acting nondepolarizing ester neuromuscular blocking drug. Anesthesiology 68:723-732
19. Savarese JJ, Ali HH, Basta SJ et al. (1989) The cardiovascular effects of mivacurium chloride (BW B1090U) in patients receiving nitrous oxide-opiate-barbiturate anesthesia. Anesthesiology 70:386-394
20. 3) twitch recovery interval in predicting the speed of spontaneous recovery from mivacurium-inducted neuromuscular blockade. Anesth Analg 80:209-210
21. Shi WZ, Fahey MR, Fisher DM, Miller RD (1989) Modification of central nervous system effects of laudanosine by inhalational anaesthetics. Br J Anaesth 63:598-600
22. Shorten G, Crawford M (1995) The neuromuscular blocking effects of high dose mivacurium in children during propofol anesthesia. Anesthesiology 83:898
23. Sockalingam I, Green DW (1995) Mivacurium-induced prolonged neuromuscular block. Br J Anaesth 74:234-236
24. Tullock W, Scott V, Smith DA, Phillips L, Cook DR et al. (1994) Kinetics/dynamics of 51W89 in liver transplant patients and in healthy patients. Anesthesiology 81:A1076
25. Viby Mogensen J (1995) Mivacurium block in patients with abnormal plasma cholinesterase. Acta Anaesthesiol Scand 39:1001-1002
26. Ward S, Boheimer N, Weatherley BC et al. (1987) Pharmacokinetics of atracurium and its metabolites in patients with normal renal function, and in patients with renal failure. Br J Anaesth 59:697-704
27. Wastila WB, Maehr RB, Turner GL, Hill DA, Savarese JJ (1996) Comparative pharmacology of cisatracurium (51W89), atracurium, and five isomers in cats. Anesthesiology 85:169-177